Interferon-gamma in Brain Tumor Immunotherapy
Authors:
- 1 January 2010
- journal article
- review article
- Published by Elsevier in Neurosurgery Clinics of North America
- Vol. 21 (1) , 77-86
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-γ sensitivity for apoptosis in human glioblastoma cellsCancer Letters, 2008
- IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathwayOncogene, 2002
- Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN‐γ‐inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T‐cell activationGlia, 2001
- Synergistic anti-tumor effects with co-expression of GM-CSF and IFN-γ in murine tumorsInternational Journal of Cancer, 1998
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Prolonged survival of mice with glioma injected intracerebrally with double cytokine—secreting cellsJournal of Neurosurgery, 1995
- Interferon-γ Induces a Decrease in the Susceptibility of Human Glioma Cells to Lysis by Lymphokine-activated Killer CellsNeurosurgery, 1994
- Molecular Mechanisms Used by Tumors to Escape Immune RecognitionJournal of Immunotherapy, 1993